RITHOLTZ WEALTH MANAGEMENT - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RITHOLTZ WEALTH MANAGEMENT ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$12,114
-64.8%
41,774
-45.4%
0.00%
-50.0%
Q4 2022$34,413
-14.0%
76,4900.0%0.00%0.0%
Q3 2022$40,000
+2.6%
76,4900.0%0.00%0.0%
Q2 2022$39,000
-77.8%
76,4900.0%0.00%
-83.3%
Q1 2022$176,000
-51.5%
76,4900.0%0.01%
-47.8%
Q4 2021$363,000
-40.3%
76,4900.0%0.02%
-45.2%
Q3 2021$608,000
-50.0%
76,490
-56.2%
0.04%
-52.3%
Q2 2021$1,216,000
-12.1%
174,6460.0%0.09%
-23.5%
Q1 2021$1,383,000
+0.7%
174,6460.0%0.12%
-12.9%
Q4 2020$1,374,000
+11.0%
174,6460.0%0.13%
-5.0%
Q3 2020$1,238,000
-23.3%
174,6460.0%0.14%
-33.2%
Q2 2020$1,615,000
+54.3%
174,646
-22.3%
0.21%
+23.8%
Q1 2020$1,047,000
-44.0%
224,646
-8.2%
0.17%
-38.5%
Q4 2019$1,869,000
-8.2%
244,646
-7.6%
0.27%
-17.3%
Q3 2019$2,035,000
+2.3%
264,646
-8.9%
0.33%
-2.9%
Q2 2019$1,990,000
-14.9%
290,5340.0%0.34%
-20.6%
Q1 2019$2,339,000
+7.5%
290,5340.0%0.43%
-13.2%
Q4 2018$2,176,000290,5340.49%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders